Search Results - "Martin, Daniel F"

Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials by Jaffe, Glenn J., Ying, Gui-Shuang, Toth, Cynthia A., Daniel, Ebenezer, Grunwald, Juan E., Martin, Daniel F., Maguire, Maureen G.

“…To evaluate associations of morphologic features with 5-year visual acuity (VA) in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)…”
Get full text

Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-related Macular Degeneration Treatments Trials by Sharma, Sumit, MD, Toth, Cynthia A., MD, Daniel, Ebenezer, MBBS, PhD, Grunwald, Juan E., MD, Maguire, Maureen G., PhD, Ying, Gui-Shuang, PhD, Huang, Jiayan, MS, Martin, Daniel F., MD, Jaffe, Glenn J., MD

“…Purpose To describe the association between morphologic features on fundus photography (FP), fluorescein angiography (FA), and optical coherence tomography…”
Get full text

Growth of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials by Grunwald, Juan E., MD, Pistilli, Maxwell, MS, Ying, Gui-shuang, PhD, Maguire, Maureen G., PhD, Daniel, Ebenezer, MBBS, MD, Martin, Daniel F., MD

“…Purpose To evaluate the growth of geographic atrophy (GA) during anti–vascular endothelial growth factor (VEGF) therapy. Design Cohort within a clinical trial…”
Get full text

Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials by Grunwald, Juan E., MD, Daniel, Ebenezer, MBBS, MD, Huang, Jiayan, MS, Ying, Gui-shuang, PhD, Maguire, Maureen G., PhD, Toth, Cynthia A., MD, Jaffe, Glenn J., MD, Fine, Stuart L., MD, Blodi, Barbara, MD, Klein, Michael L., MD, Martin, Alison A, Hagstrom, Stephanie A., PhD, Martin, Daniel F., MD

“…Purpose To describe risk factors for geographic atrophy (GA) in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Design Cohort…”
Get full text

Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials by Grunwald, Juan E., MD, Pistilli, Maxwell, MS, Daniel, Ebenezer, MBBS, MD, Ying, Gui-Shuang, PhD, Pan, Wei, MS, Jaffe, Glenn J., MD, Toth, Cynthia A., MD, Hagstrom, Stephanie A., PhD, Maguire, Maureen G., PhD, Martin, Daniel F., MD

“…Purpose To estimate the incidence, size, and growth rate of geographic atrophy (GA) during 5 years of follow-up among participants in the Comparison of…”
Get full text

Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials by Daniel, Ebenezer, MBBS, PhD, Toth, Cynthia A., MD, Grunwald, Juan E., MD, Jaffe, Glenn J., MD, Martin, Daniel F., MD, Fine, Stuart L., MD, Huang, Jiayan, MS, Ying, Gui-shuang, MD, PhD, Hagstrom, Stephanie A., PhD, Winter, Katrina, BS, Maguire, Maureen G., PhD

“…Objective To describe risk factors for scar in eyes treated with ranibizumab or bevacizumab for neovascular age-related macular degeneration (AMD). Design…”
Get full text

Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials by Jaffe, Glenn J., MD, Martin, Daniel F., MD, Toth, Cynthia A., MD, Daniel, Ebenezer, MPH, PhD, Maguire, Maureen G., PhD, Ying, Gui-Shuang, PhD, Grunwald, Juan E., MD, Huang, Jiayan, MS

“…Objective To describe the effects of treatment for 1 year with ranibizumab or bevacizumab on macular morphology and the association of macular morphology with…”
Get full text

Millennial‐Scale Vulnerability of the Antarctic Ice Sheet to Regional Ice Shelf Collapse by Martin, Daniel F., Cornford, Stephen L., Payne, Antony J.

“…The Antarctic Ice Sheet (AIS) remains the largest uncertainty in projections of future sea level rise. A likely climate‐driven vulnerability of the AIS is…”
Get full text

Pseudodrusen and Incidence of Late Age-Related Macular Degeneration in Fellow Eyes in the Comparison of Age-Related Macular Degeneration Treatments Trials by Zhou, Qiang, MD, Daniel, Ebenezer, MBBS, PhD, Maguire, Maureen G., PhD, Grunwald, Juan E., MD, Martin, E. Revell, BA, Martin, Daniel F., MD, Ying, Gui-shuang, PhD

“…Purpose To evaluate the association between pseudodrusen and incidence of late age-related macular degeneration (AMD) in fellow eyes of patients with…”
Get full text

Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) by Daniel, Ebenezer, MPH, PhD, Shaffer, James, MS, Ying, Gui-shuang, PhD, Grunwald, Juan E., MD, Martin, Daniel F., MD, Jaffe, Glenn J., MD, Maguire, Maureen G., PhD

“…Purpose To compare baseline characteristics, visual acuity (VA), and morphologic outcomes between eyes with retinal angiomatous proliferation (RAP) and all…”
Get full text

Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration by Ying, Gui-shuang, PhD, Huang, Jiayan, MS, Maguire, Maureen G., PhD, Jaffe, Glenn J., MD, Grunwald, Juan E., MD, Toth, Cynthia, MD, Daniel, Ebenezer, MBBS, MS, MPH, Klein, Michael, MD, Pieramici, Dante, MD, Wells, John, MD, Martin, Daniel F., MD

“…Objective To determine the baseline predictors of visual acuity (VA) outcomes 1 year after treatment with ranibizumab or bevacizumab for neovascular…”
Get full text

Postinjection Endophthalmitis in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) by Meredith, Travis A., MD, McCannel, Colin A., MD, Barr, Charles, MD, Doft, Bernard H., MD, Peskin, Ellen, MA, Maguire, Maureen G., PhD, Martin, Daniel F., MD, Prenner, Jonathan L., MD

“…Objective To describe the incidence and outcomes of endophthalmitis after intravitreal injections of anti–vascular endothelial growth factor agents in the…”
Get full text

Association between Antiplatelet or Anticoagulant Drugs and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials by Ying, Gui-shuang, PhD, Maguire, Maureen G., PhD, Daniel, Ebenezer, PhD, Grunwald, Juan E., MD, Ahmed, Osama, Martin, Daniel F., MD

“…Purpose To evaluate the association between use of antiplatelet or anticoagulant drugs and retinal or subretinal hemorrhage in participants with neovascular…”
Get full text

Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT) by Ying, Gui-shuang, PhD, Maguire, Maureen G., PhD, Daniel, Ebenezer, MBBS, PhD, Ferris, Frederick L., MD, Jaffe, Glenn J., MD, Grunwald, Juan E., MD, Toth, Cynthia A., MD, Huang, Jiayan, MS, Martin, Daniel F., MD

“…Purpose To evaluate the association of baseline characteristics and early visual acuity (VA) response with visual outcomes at years 1 or 2 in the Comparison of…”
Get full text

Simulating ice-shelf extent using damage mechanics by Kachuck, Samuel B., Whitcomb, Morgan, Bassis, Jeremy N., Martin, Daniel F., Price, Stephen F.

“…Inaccurate representations of iceberg calving from ice shelves are a large source of uncertainty in mass-loss projections from the Antarctic ice sheet. Here,…”
Get full text

Utility of intraoperative optical coherence tomography during vitrectomy surgery for vitreomacular traction syndrome by Ehlers, Justis P, Tam, Tiffany, Kaiser, Peter K, Martin, Daniel F, Smith, Gina M, Srivastava, Sunil K

“…To assess the microarchitectural changes occurring during surgery for vitreomacular traction using intraoperative optical coherence tomography (iOCT). A…”
Get full text

Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials by Cuilla, Thomas A., MD, Ying, Gui-shuang, PhD, Maguire, Maureen G., PhD, Martin, Daniel F., MD, Jaffe, Glenn J., MD, Grunwald, Juan E., MD, Daniel, Ebenezer, MBBS, PhD, Toth, Cynthia A., MD

“…Objective To assess the association of the vitreomacular interface with outcomes of eyes treated with anti–vascular endothelial growth factor drugs for…”
Get full text

Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials by Ying, Gui-shuang, Kim, Benjamin J, Maguire, Maureen G, Huang, Jiayan, Daniel, Ebenezer, Jaffe, Glenn J, Grunwald, Juan E, Blinder, Kevin J, Flaxel, Christina J, Rahhal, Firas, Regillo, Carl, Martin, Daniel F

“…Although anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration (AMD) results in improved vision overall, loss of…”
Get more information

Pharmacogenetics for Genes Associated with Age-related Macular Degeneration in the Comparison of AMD Treatments Trials (CATT) by Hagstrom, Stephanie A., PhD, Ying, Gui-shuang, PhD, Pauer, Gayle J.T., BA, Sturgill-Short, Gwen M., BA, Huang, Jiayan, MS, Callanan, David G., MD, Kim, Ivana K., MD, Klein, Michael L., MD, Maguire, Maureen G., PhD, Martin, Daniel F., MD

“…Purpose To evaluate the pharmacogenetic relationship between genotypes of single nucleotide polymorphisms (SNPs) known to be associated with age-related…”
Get full text

VEGFR2 Gene Polymorphisms and Response to Anti–Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration by Hagstrom, Stephanie A., PhD, Ying, Gui-shuang, PhD, Maguire, Maureen G., PhD, Martin, Daniel F., MD, Gibson, Jane, PhD, Lotery, Andrew, MD, Chakravarthy, Usha, PhD

“…Purpose A previously published study demonstrated a pharmacogenetic association between the minor alleles of 2 VEGFR2 single nucleotide polymorphisms (SNPs)…”
Get full text